Does the toxicity of endocrine therapy persist into long-term survivorship?: Patient-reported outcome results from a follow-up study beyond a 10-year-survival

BACKGROUND: Endocrine treatment (ET) is a highly effective breast cancer treatment but can distinctly impair breast cancer patients’ quality of life (QOL). In a patient-reported outcome (PROs) study conducted by the authors in 2011, patients reported higher ET-induced symptom levels than known from...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmen, Albertini, Anne, Oberguggenberger, Monika, Sztankay, Daniel, Egle, Johannes, Giesinger, Verena, Meraner, Michael, Hubalek, Christine, Brunner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036266/
https://www.ncbi.nlm.nih.gov/pubmed/36418518
http://dx.doi.org/10.1007/s10549-022-06808-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036266/
https://www.ncbi.nlm.nih.gov/pubmed/36418518
http://dx.doi.org/10.1007/s10549-022-06808-9

Ejemplares similares